Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07062237 · ClinicalTrials.gov registry record · NA

A Randomized Clinical Trial Comparing Embryo Euploidy Rates Following Ultrashort Versus Standard Abstinence

A NA study of Infertility and Male Factor Infertility, sponsored by UConn Health.

Recruiting
Registry status
NA
Development phase
187
Enrollment target
1
Study location

NCT07062237: Recruiting NA study of Infertility and Male Factor Infertility, sponsored by UConn Health.

NCT07062237 is a NA study of Infertility and Male Factor Infertility that is actively recruiting participants, run by UConn Health. The registered enrollment target is 187 participants, below the 7,587-participant average among 74 other Infertility trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07062237, a NA study of Infertility and Male Factor Infertility, is actively recruiting participants, sponsored by UConn Health.

RECRUITING
Registry status
NA
Development phase
187 participants
Enrollment target
1
Study location

Study Summary

This research is being done to determine if producing sperm after an ultrashort period of abstinence (1 hour of abstinence) will be effective in improving the rates of embryos with normal chromosomes (structures that carry genetic information) during in vitro fertilization (IVF) treatment. The investigators hypothesize that a shorter period of abstinence is effective at improving rates of normal chromosomes among embryos.

Primary Outcome

Rate of embryos with normal chromosomes in both groups

Interventions

  • OTHER Ultrashort abstinence
  • OTHER Standard abstinence

Study Locations (1)

Connecticut

  • The Center for Advanced Reproductive Services, P.C. - Farmington

Trial Details

FieldValue
Enrollment Target 187 participants
Start Date 2025-07
Est. Completion 2027-06
Phase NA
UConn Health

178 total trials

What NCT07062237 shows while recruiting

NCT07062237 is an interventional study that assigns participants to a tested intervention. The registered 187 participants enrollment target is mid-sized for trials with a published cap, below the 7,587-participant average among 74 other Infertility trials with a reported enrollment target (98% lower).

The record links to 2 conditions, with Infertility appearing as the primary indexed condition, and to 2 interventions - of which Ultrashort abstinence is the first listed.

NCT07062237 reports a single indexed study location in Connecticut.

Frequently Asked Questions

What is clinical trial NCT07062237 about?

NCT07062237 is a clinical study titled "A Randomized Clinical Trial Comparing Embryo Euploidy Rates Following Ultrashort Versus Standard Abstinence". This research is being done to determine if producing sperm after an ultrashort period of abstinence (1 hour of abstinence) will be effective in improving the rates of embryos with normal chromosomes (structures that carry genetic information) during in vitro fertilization (IVF) treatment. The inves...

What is the current status of trial NCT07062237?

This trial is currently recruiting. It is a NA study. The enrollment target is 187 participants. The study started on 2025-07. Estimated completion is 2027-06.

What conditions does trial NCT07062237 study?

This clinical trial studies the following conditions: Infertility, Male Factor Infertility.

What interventions are being tested in trial NCT07062237?

The interventions under investigation include: Ultrashort abstinence (OTHER), Standard abstinence (OTHER).

Who is sponsoring clinical trial NCT07062237?

This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07062237 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infertility

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07062237's enrollment target sits among peer trials

187 43rd of 74 higher than 32 of 74 other Infertility trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Infertility trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06153251 · 187 participants · Phase 1

    A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma

  • NCT06254898 · 187 participants · NA

    Use of Incentives for Stressful Medical Procedures

  • NCT07217574 · 187 participants

    Program in Oncology for Tribal Health Systems.

  • NCT07306559 · 187 participants · Phase 1

    A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT07062237, the US trial registry maintained by the National Library of Medicine. NCT07062237 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.